VAN NOSTRAND ROBERT L - Insider Non-Derivative Transactions at Intra-Cellular Therapies, Inc. (ITCI) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 28, 2024, VAN NOSTRAND ROBERT L's relationship to Intra-Cellular Therapies, Inc. (ITCI) is Director, and currently has 11,340 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ITCI insiders.
Data Source: SEC.
VAN NOSTRAND ROBERT L - Insider Non-Derivative Transactions of ITCI Common Stock
VAN NOSTRAND ROBERT L - Insider Non-Derivative Transactions at ITCI
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 29, 2024 | Acquisition -- (Common Stock) | 83 | 68.49 | 11340 |
| Jun 24, 2024 | M -- (Common Stock) | 1567 | 0 | 11257 |
| Jun 19, 2024 | Sell -- (Common Stock) | 11109 | 76.07 | 9690 |
| Jun 19, 2024 | Sell -- (Common Stock) | 8891 | 75.71 | 20799 |
| Jun 19, 2024 | M -- (Common Stock) | 20000 | 16.86 | 29690 |
| Apr 1, 2024 | Acquisition -- (Common Stock) | 79 | 69.2 | 9690 |
| Feb 28, 2024 | Sell -- (Common Stock) | 10349 | 73.14 | 9611 |
| Feb 28, 2024 | Sell -- (Common Stock) | 9651 | 72.71 | 19960 |
| Feb 28, 2024 | M -- (Common Stock) | 20000 | 18.56 | 29611 |
| Jan 1, 2024 | Acquisition -- (Common Stock) | 76 | 71.62 | 9611 |
| Oct 1, 2023 | Acquisition -- (Common Stock) | 105 | 52.09 | 9535 |
| Jul 1, 2023 | Acquisition -- (Common Stock) | 85 | 63.32 | 9430 |
| Apr 18, 2023 | Sell -- (Common Stock) | 10000 | 63 | 9345 |
| Apr 18, 2023 | M -- (Common Stock) | 10000 | 13.05 | 19345 |
| Apr 1, 2023 | Acquisition -- (Common Stock) | 95 | 54.15 | 9345 |
| Dec 31, 2022 | Acquisition -- (Common Stock) | 97 | 52.92 | 9250 |